MAXWELLIA LTD
Company number 08573637 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£10,403,649
Balance sheet as at 2024-10-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2013-06-18
- Employees
- 10 (2024 accounts · was 7 in 2023)
- Registered office
- 30s1a-D Alderley Park, Alderley Edge, East Cheshire, England, SK10 4TG
- Postcode
- SK10 4TG
- Capital
- 9 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-10-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-12-01
- Next due by
- 2026-12-15
Nature of business (SIC)
- 46460 Wholesale of pharmaceutical goods
Officers 5 current · 5 resigned
Data protection registration
Registered with the ICO as a data protection fee payer — ZA283152 (Tier 1), registered since 2017.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- maxwellia.com
- Phone
- 0418410042
Maxwellia is a trailblazing, female-founded consumer healthcare company revolutionising access to medicines.
Previous registered addresses 5
| Address | Changed on |
|---|---|
| ALDERLEY PARK 20F38 ALDERLEY EDGE, CHESHIRE, SK10 4TG, ENGLAND | 2018-12-20 |
| 20F38 20F38, ALDERLEY PARK, ALDERLEY EDGE, SK10 4TG, ENGLAND | 2018-12-20 |
| 20F38 ALDERLEY PARK, ALDERLEY EDGE, MACCLESFIELD, CHESHIRE, SK10 4TG, UNITED KINGDOM | 2018-12-14 |
| 20-22 WENLOCK ROAD, LONDON, N1 7GU | 2018-12-06 |
| 145-157 ST JOHN STREET, LONDON, EC1V 4PW | 2014-10-01 |
Among its peers
Top 10%
by shareholders' funds, of 24 similar companies in SK
Trading since 2013.
Competitors Stockport
This company ranks 2 among wholesale of pharmaceutical goods in Stockport.
The class of 2013
23%
of the 530,502 companies incorporated in 2013 are still active today; 75% have since been dissolved.
A fact about the year, not a forecast for this company.